For instance, methylseleninic acid (MSeA) overcomes gefitinib resistance in NSCLC through the asparagine-MET-TOPK axis 143, while ERK2-mediated phosphorylation of TOPK enhances RCC cell sensitivity to sorafenib 52. The gene discussed is MAPK1; the disease is non-small cell lung carcinoma.